Lack of the scavenger receptor CD36 alters microglial phenotypes after neonatal stroke

Fan Li1,2, Joel Faustino1, Moon-Sook Woo1

  • 1Department of Neurology, University of California San Francisco, San Francisco, California, USA.

Insights

In neonatal stroke, the scavenger receptor CD36 is crucial for microglial neuroprotection. Lack of CD36 exacerbates brain injury by altering microglial function and chemokine accumulation.

Area of Science:

  • Neuroscience
  • Immunology
  • Developmental Biology

Background:

  • Brain development stage influences stroke pathophysiology and neuroinflammation.
  • Microglia act as neuroprotectants in neonatal stroke, unlike in adult models.
  • Scavenger receptor CD36 deficiency exacerbates neonatal stroke injury.

Purpose of the Study:

  • To investigate the impact of CD36 deficiency on microglial phenotypes in neonatal stroke.
  • To understand how CD36 absence affects microglial responses to ischemic injury in the developing brain.

Main Methods:

  • Neonatal mice (postnatal day 10) underwent transient middle cerebral artery occlusion.
  • Microglia were isolated from injured brain regions for analysis.
  • RT-PCR and biochemical assays were used to assess gene expression and microglial function.

Main Results:

  • Pro-inflammatory gene expression in activated microglia was largely unaffected by CD36 deficiency.
  • CD36 absence enhanced MCP-1 accumulation and altered CD11b+/CD45+ cell counts.
  • CD36 deficiency did not affect superoxide accumulation or TNFα and IL-1β levels.

Conclusions:

  • CD36 plays a critical role in modulating microglial function post-neonatal stroke.
  • While not affecting all inflammatory markers, CD36 deficiency alters specific microglial responses, impacting injury outcomes.

Related Concept Videos